Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Divis Laboratories' surges as its Q1 net jumps 23%

16-Aug2016

Divis Laboratories' surges as its Q1 net jumps 23%

Divis Laboratories is currently trading at Rs. 1275.05, up by 84.75 points or 7.12% from its previous closing of Rs. 1190.30 on the BSE.

The scrip opened at Rs. 1200.00 and has touched a high and low of Rs. 1279.90 and Rs. 1200.00 respectively. So far 72,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1279.90 on 16-Aug-2016 and a 52 week low of Rs. 918.10 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs. 1279.90 and Rs. 1144.10 respectively. The current market cap of the company is Rs. 33,855.21 crore.

The promoters holding in the company stood at 52.08%, while Institutions and Non-Institutions held 33.94% and 13.98% respectively.

The company has registered growth of 23.10% in its net profit at Rs 301.81 crore for first quarter ended June 30, 2016 as compared to Rs 245.18 crore for the same quarter in the previous year. Total income of the company increased by 21.53% at Rs 1024.39 crore for quarter under review as compared to Rs 842.93 crore for the quarter ended June 30, 2015.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry



Related News

View all news

Jammu & Kashmir Bank trades higher on the bourses

The Jammu & Kashmir Bank is currently trading at Rs. 42.65, up by 0.45 points or 1.07% from its previous closing of Rs. 42.20 on the BSE.The scrip opened at Rs. 42.25 and has touched a high and......

IndiGo trades in green on the BSE

Interglobe Aviation is currently trading at Rs. 843.65, up by 7.30 points or 0.87% from its previous closing of Rs. 836.35 on the BSE.The scrip opened at Rs. 848.10 and has touched a high and low of Rs.......

Mphasis slips despite reporting 37% rise in Q2 consolidated net profit

Mphasis is currently trading at Rs. 1070.00, down by 53.10 points or 4.73% from its previous closing of Rs. 1123.10 on the BSE.The scrip opened at Rs. 1107.00 and has touched a high and low of Rs. 1119.90......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......